Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C to reduce harmful effects of radioiodine in thyroid cancer
IRCT2017041833505N1Phase 4Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ascorbic acid in thyroid cancer, sponsored by Shiraz University of Medical Sciences. Started May 2017; status: completed.
02
Drugs
ascorbic acid
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on IRCT2017041833505N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017041833505N1.